Saturday, May 2, 2026

South Korean Researchers Crack the Dry-Electrode Bottleneck: 4x Faster Processing, 3x Stronger EV Battery Electrodes

A research team has improved eco-friendly battery manufacturing, reducing production time by 75% and increasing energy storage capacity.

NVIDIA Stock Surges Nearly 3% as U.S. Tech Giants Ramp Up AI Investments

NVIDIA's stock rebounds as U.S. tech firms plan $325B AI investment, raising target prices amid competitive AI landscape.

New Study Reveals Radiation Dose Reduction May Cause Tumor Recurrence in Meningioma Patients

A study reveals that lower radiation doses for benign meningiomas near the optic nerve may lead to worse long-term outcomes and tumor regrowth.

Health

South Korea Initiates Preparations for AI Basic Medical Care to Ensure Universal Access to High-quality Medical Services

The South Korean government is launching AI Basic Healthcare to improve medical access and address regional disparities in healthcare.

PharmGen Science Releases Tabapheno Extended-Release for Dyslipidemia Treatment

PharmGen Science launches Tabapheno Extended-Release Tablets for mixed dyslipidemia, enhancing treatment convenience and adherence.

GreenVet Announces CaniCancer-FFPE, a Precision Cancer Diagnostic Solution for Pets

GreenVet introduces CaniCancer, a unified cancer diagnostic solution for pets, streamlining biopsy and genetic testing for faster treatment.

Daewoong Pharmaceutical and Primind’s Strategic Investment in American Biotech General Proximity

Daewoong Pharmaceutical invests in biotech firms to enhance drug development using Induced Proximity technology and expand globally.

Why 20 Years of Stem Cell Therapy Research Still Lacks Proven Results

Stem cell therapy shows promise but faces hurdles in clinical applications and approvals, with few successful treatments available.
Latest

South Korea’s ARPA-H Project Revolutionizes Elderly Mental Health Solutions

South Korea will officially enter 'super-aged society' by late 2024 or early 2025, raising concerns over elderly mental health issues.

SillaJen’s Breakthrough Cancer BAL0891 Drug Set for ASCO 2026 Reveal

SillaJen's anticancer drug BAL0891 will be presented at the ASCO Annual Meeting, currently in Phase 1 trials for solid tumors and AML.

Nesuparib: The Revolutionary Dual-Inhibitor for Pancreatic Cancer – Can It Outperform Existing Treatments?

Nesuparib shows promise in inhibiting pancreatic cancer metastasis, offering hope for patients regardless of BRCA mutation status.

Lunit’s AI-based bile duct cancer study selected for rapid oral presentation at U.S. oncology conference

Lunit will present five research abstracts at ASCO 2026, showcasing the expanding role of AI biomarkers in cancer treatment.

Verismo unveils preclinical data on improved antitumor efficacy and safety of blood cancer CAR-T at AACR

HLB Innovation's SynKIR-310 shows improved antitumor activity and safety in preclinical trials, achieving 100% survival in mice.

JW Life Science launches medical care brand “Dr. Claro”

JW Life Science launches "Dr. Claro," a medical care brand with five certified products for wound management and skin protection.

CG Bio’s EasyMade TI: The First Custom Titanium Implant Approved by FDA 510(k) – What It Means for Patients

CG Bio's EasyMade TI titanium implant receives FDA 510(k) approval, marking a milestone for customized implants in the U.S. market.

Stage 3 lung cancer patients over 70 can receive “active treatment” so “should not give up”

A study shows elderly patients (70+) with stage 3 lung cancer can complete standard treatment, challenging age-related treatment hesitance.

Alzheimer’s Breakthrough: Monthly Injections of IVL3003 vs. GB-5001A—Which is More Effective?

New long-acting injectable formulations of donepezil for Alzheimer's aim to improve adherence and efficacy, easing caregiver burdens.

Breakthrough in neuroscience research…precision correction technology for microscope image distortion developed

KAIST's research team developed a software algorithm to correct microscope image distortions, enhancing biological observation without extra hardware.

ABL209: The Promising Dual Antibody ADC Revolutionizing Cancer Treatment in 2026

ABL Bio's ABL209 shows promising anti-cancer effects with broad safety in preclinical studies, advancing to Phase 1 trials in the U.S.

Celltrion’s Steqeyma IV Approval: What This Means for Celltrion’s Growth in Japan’s Autoimmune Drug Market

Celltrion's Steqeyma IV formulation gains approval in Japan, expanding treatment for Crohn's disease and enhancing market competitiveness.

KRISS Develops Innovative Toxicity Assessment System Using Water Flea Heart Rate Measurement

KRISS has developed an automated system to measure water flea heart rates for precise toxicity assessments, enhancing environmental research.

Unlocking Triple Negative Breast Cancer: How Gene-Protein Analysis Predicts Treatment Success

A study reveals that analyzing genetic and protein data can predict chemotherapy effectiveness in triple-negative breast cancer, aiding personalized treatment.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.